Stay updated on Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page.

Latest updates to the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2 deployed; no visible changes to Study Details page content or user-facing behavior.SummaryDifference0.1%

- Check13 days agoChange DetectedPublications are now described as auto-filled from PubMed, and the revision is labeled as v3.3.1. The previous wording about PubMed-sourced publications and the v3.2.0 revision reference have been removed.SummaryDifference0.1%

- Check21 days agoChange DetectedNotice about government funding and operating status was removed from the page; this status notice previously informed users about potential delays and updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check35 days agoChange DetectedThe two screenshots show the same study record with minor layout adjustments; there are no changes to core content like eligibility criteria, primary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check71 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.SummaryDifference0.2%

Stay in the know with updates to Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page.